Literature DB >> 8328457

Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD).

J R Gilbert1, J M Stajich, S Wall, S C Carter, H Qiu, J M Vance, C S Stewart, M C Speer, J Pufky, L H Yamaoka.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is a slowly progressive primary disease of muscle which is usually inherited as an autosomal dominant disorder. FSHD has been localized to the long arm of chromosome 4, specifically to the 4q3.5-qter region. Initially published linkage studies showed no evidence for heterogeneity in FSHD. In the present study we have examined individuals in seven FSHD families. Two-point lod scores show significant evidence for linkage for D4S163 (lod score 3.04 at recombination fraction .21) and D4S139 (lod score 3.84 at recombination fraction .20). D4S171 also gave a positive score (lod score 2.56 at recombination fraction .24). Significant evidence for heterogeneity was found for each of the three markers. Multipoint linkage analysis in this region resulted in a peak multipoint lod score of 6.47. The multipoint analysis supported the two-point studies with odds of 20:1 showing linkage and heterogeneity over linkage and homogeneity. Five of the seven families gave a posterior probability of > 95% of being of the linked type, while two families appeared unlinked to this region of 4q (P < .01%). Individuals in the two unlinked families met the clinical criteria for the diagnosis of FSHD, including facial weakness, clavicular flattening, scapula winging, proximal muscle weakness, and myopathic changes on muscle biopsies without inflammatory or mitochondrial pathology. This study demonstrates genetic heterogeneity in FSHD and has important implications for both genetic counseling and the elucidation of the etiology of FSHD.

Entities:  

Mesh:

Year:  1993        PMID: 8328457      PMCID: PMC1682358     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  14 in total

1.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy.

Authors:  C Wijmenga; J E Hewitt; L A Sandkuijl; L N Clark; T J Wright; H G Dauwerse; A M Gruter; M H Hofker; P Moerer; R Williamson
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

2.  Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization.

Authors:  C Wijmenga; G W Padberg; P Moerer; J Wiegant; L Liem; O F Brouwer; E C Milner; J L Weber; G B van Ommen; L A Sandkuyl
Journal:  Genomics       Date:  1991-04       Impact factor: 5.736

3.  Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium.

Authors:  M Sarfarazi; C Wijmenga; M Upadhyaya; B Weiffenbach; C Hyser; K Mathews; J Murray; J Gilbert; M Pericak-Vance; P Lunt
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

4.  Linkage studies in facioscapulohumeral muscular dystrophy (FSHD).

Authors:  J R Gilbert; J M Stajich; M C Speer; J M Vance; C S Stewart; L H Yamaoka; F Samson; M Fardeau; T G Potter; A D Roses
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

5.  DNA marker applicable to presymptomatic and prenatal diagnosis of facioscapulohumeral disease.

Authors:  M Upadhyaya; P W Lunt; M Sarfarazi; W Broadhead; J Daniels; M Owen; P S Harper
Journal:  Lancet       Date:  1990-11-24       Impact factor: 79.321

6.  Estimating the power of a proposed linkage study for a complex genetic trait.

Authors:  L M Ploughman; M Boehnke
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

7.  Evidence against location of the gene for facioscapulohumeral muscular dystrophy on the distal long arm of chromosome 14.

Authors:  P W Lunt; J G Noades; M Upadhyaya; M Sarfarazi; P S Harper
Journal:  J Neurol Sci       Date:  1988-12       Impact factor: 3.181

8.  Genetic linkage studies in Alzheimer's disease families.

Authors:  M A Pericak-Vance; L H Yamaoka; C S Haynes; M C Speer; J L Haines; P C Gaskell; W Y Hung; C M Clark; A L Heyman; J A Trofatter
Journal:  Exp Neurol       Date:  1988-12       Impact factor: 5.330

9.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Location of facioscapulohumeral muscular dystrophy gene on chromosome 4.

Authors:  C Wijmenga; R R Frants; O F Brouwer; P Moerer; J L Weber; G W Padberg
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321

View more
  20 in total

Review 1.  The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy.

Authors:  Silvère M van der Maarel; Rune R Frants
Journal:  Am J Hum Genet       Date:  2005-01-24       Impact factor: 11.025

2.  Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level.

Authors:  Rinse Klooster; Kirsten Straasheijm; Bharati Shah; Janet Sowden; Rune Frants; Charles Thornton; Rabi Tawil; Silvère van der Maarel
Journal:  Eur J Hum Genet       Date:  2009-10-07       Impact factor: 4.246

3.  New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination?

Authors:  Mouna Barat-Houari; Karine Nguyen; Rafaëlle Bernard; Céline Fernandez; Catherine Vovan; Corinne Bareil; Philippe Khau Van Kien; Delphine Thorel; Sylvie Tuffery-Giraud; Francis Vasseur; Shahram Attarian; Jean Pouget; Anne Girardet; Nicolas Lévy; Mireille Claustres
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

4.  Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: diagnostic approach for sporadic and familial cases.

Authors:  E Bakker; M J Van der Wielen; E Voorhoeve; P F Ippel; G W Padberg; R R Frants; C Wijmenga
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

5.  Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD.

Authors:  M Upadhyaya; J Maynard; M T Rogers; P W Lunt; P Jardine; D Ravine; P S Harper
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

Review 6.  Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Authors:  Charis L Himeda; Takako I Jones; Peter L Jones
Journal:  Antioxid Redox Signal       Date:  2014-12-04       Impact factor: 8.401

7.  Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.

Authors:  Charis L Himeda; Céline Debarnot; Sachiko Homma; Mary Lou Beermann; Jeffrey B Miller; Peter L Jones; Takako I Jones
Journal:  Mol Cell Biol       Date:  2014-03-17       Impact factor: 4.272

Review 8.  Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?

Authors:  Mark Richards; Frédérique Coppée; Nick Thomas; Alexandra Belayew; Meena Upadhyaya
Journal:  Hum Genet       Date:  2011-10-09       Impact factor: 4.132

Review 9.  Investigation of muscle disease.

Authors:  F L Mastaglia; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

10.  De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1).

Authors:  P E Jardine; M C Koch; P W Lunt; J Maynard; K D Bathke; P S Harper; M Upadhyaya
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.